Epithelial ovarian cancer (EOC) cells are under intrinsic oxidative stress, which alters metabolic activity and reduces apoptosis. Key oxidative stress enzymes, including myeloperoxidase (MPO) and inducible nitric oxide synthase (iNOS), are upregulated and colocalized in EOC cells. Oxidative stress is also regulated, in part, by superoxide dismutase (SOD) and hypoxia-inducible factor (HIF) 1a. Dichloroacetate (DCA) converts anaerobic to aerobic metabolism and thus was utilized to determine the effects on apoptosis, iNOS, MPO, extracellular SOD (SOD-3), and HIF-1a, in EOC cells. Protein and messenger RNA (mRNA) levels of iNOS, MPO, SOD-3, and HIF-1a were evaluated by immunoprecipitation/Western blot and real-time reverse transcriptase-polymerase chain reaction (RT-PCR), respectively, utilizing SKOV-3 and MDAH-2774 treated with DCA. Apoptosis was assessed by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) and caspase 3 assays. Dichloroacetate induced apoptosis, reduced MPO, iNOS, and HIF-1a, whereas increased SOD, in both EOC cell lines. In conclusion, reduction of enhanced oxidative stress-induced apoptosis of EOC cells, which may serve as future therapeutic intervention for ovarian cancer.
BarakatRRMarkmanMRandallM. Principles and Practice of Gynecologic Oncology. 5th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2009.
2.
FloraSJ. Role of free radicals and antioxidants in health and disease. Cell Mol Biol (Noisy-le-grand). 2007;53(1):1–2.
3.
WisemanHHalliwellB. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J. 1996;313(Pt 1):17–29. PMCID: 1216878.
4.
LiHFanXHoughtonJ. Tumor microenvironment: the role of the tumor stroma in cancer. J Cell Biochem. 2007;101(4):805–815.
5.
SaedGMAli-FehmiRJiangZLMyeloperoxidase serves as a redox switch that regulates apoptosis in epithelial ovarian cancer. Gynecol Oncol. 2010;116(2):276–281.
6.
MotooYShimasakiTIshigakiYNakajimaHKawakamiKMinomotoT. Metabolic disorder, inflammation, and deregulated molecular pathways converging in pancreatic cancer development: implications for new therapeutic strategies. Cancers. 2011;3(1):446–460.
7.
OzbenT. Oxidative stress and apoptosis: impact on cancer therapy. J Pharm Sci. 2007;96(9):2181–2196.
8.
GibelliniLPintiMNasiMInterfering with ROS metabolism in cancer cells: the potential role of quercetin. Cancers. 2010(2):1288–1311.
9.
PelicanoHCarneyDHuangP. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat. 2004;7(2):97–110.
10.
ReuterSGuptaSCChaturvediMMAggarwalBB. Oxidative stress, inflammation, and cancer: how are they linked?Free Radic Biol Med. 2010;49(11):1603–1616. PMCID: 2990475.
11.
ZelkoINMarianiTJFolzRJ. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Rad Biol Med. 2002;33(3):337–349.
12.
MichelakisEDWebsterLMackeyJR. Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer. Br J Cancer. 2008;99(7):989–994. PMCID: 2567082.
13.
KroemerGPouyssegurJ. Tumor cell metabolism: cancer’s Achilles’ heel. Cancer Cell. 2008;13(6):472–482.
14.
FangJSekiTMaedaH. Therapeutic strategies by modulating oxygen stress in cancer and inflammation. Adv Drug Deliv Rev. 2009;61(4):290–302.
15.
VirgiliFMarinoM. Regulation of cellular signals from nutritional molecules: a specific role for phytochemicals, beyond antioxidant activity. Free Radic Biol Med. 2008;45(9):1205–1216.
16.
SurhYJKunduJKNaHKLeeJS. Redox-sensitive transcription factors as prime targets for chemoprevention with anti-inflammatory and antioxidative phytochemicals. J Nutr. 2005;135(12 suppl):2993S–3001S.
17.
KatoMLiJChuangJLChuangDT. Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol. Structure. 2007;15(8):992–1004. PMCID: 2871385.
18.
DiamondMPEl-HammadyEWangRSaedG. Regulation of matrix metalloproteinase-1 and tissue inhibitor of matrix metalloproteinase-1 by dichloroacetic acid in human fibroblasts from normal peritoneum and adhesions. Fertil Steril. 2004;81(1):185–190.
19.
SaedGMDiamondMP. Modulation of the expression of tissue plasminogen activator and its inhibitor by hypoxia in human peritoneal and adhesion fibroblasts. Fertil Steril. 2003;79(1):164–168.
20.
SuhYAArnoldRSLassegueBCell transformation by the superoxide-generating oxidase Mox1. Nature. 1999;401(6748):79–82.
21.
GatenbyRAGilliesRJ. Why do cancers have high aerobic glycolysis?Nat Rev Cancer. 2004;4(11):891–899.
22.
GeisztMKoppJBVarnaiPLetoTL. Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci USA. 2000;97(14):8010–8014. PMCID: 16661.
23.
NemotoSTakedaKYuZXFerransVJFinkelT. Role for mitochondrial oxidants as regulators of cellular metabolism. Mol Cell Biol. 2000;20(19):7311–7318. PMCID: 86285.
24.
BanerjeeSRandevaHChambersAE. Mouse models for preeclampsia: disruption of redox-regulated signaling. Reprod Biol Endocrinol. 2009;7:4. PMCID: 2632643.
25.
TapiaPC. Sublethal mitochondrial stress with an attendant stoichiometric augmentation of reactive oxygen species may precipitate many of the beneficial alterations in cellular physiology produced by caloric restriction, intermittent fasting, exercise and dietary phytonutrients: “Mitohormesis” for health and vitality. Med Hypotheses. 2006;66(4):832–843.
26.
CairnsRAHarrisISMakTW. Regulation of cancer cell metabolism. Nat Rev Cancer. 2011;11(2):85–95.
27.
KinnulaVLCrapoJD. Superoxide dismutases in malignant cells and human tumors. Free Radic Biol Med. 2004;36(6):718–744.
28.
TandonVSharmaSMahajanABardiG. Oxidative stress: a novel strategy in cancer treatment. JK Sci. 2005;7(1):56.
29.
HilemanEOLiuJAlbitarMKeatingMJHuangP. Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity. Cancer Chemother Pharmacol. 2004;53(3):209–219.
30.
BhosleSMPandeyBNHuilgolNGMishraKP. Membrane oxidative damage and apoptosis in cervical carcinoma cells of patients after radiation therapy. Methods Cell Sci. 2002;24(1-3):65–68.
31.
HuangPFengLOldhamEAKeatingMJPlunkettW. Superoxide dismutase as a target for the selective killing of cancer cells. Nature. 2000;407(6802):390–395.
32.
StorzP. Reactive oxygen species in tumor progression. Front Biosci. 2005;10:1881–1896.
33.
FleischauerATOlsonSHMignoneLSimonsenNCaputoTAHarlapS. Dietary antioxidants, supplements, and risk of epithelial ovarian cancer. Nutr Cancer. 2001;40(2):92–98.
34.
SchuurmanAGGoldbohmRABrantsHAvan den BrandtPA. A prospective cohort study on intake of retinol, vitamins C and E, and carotenoids and prostate cancer risk (Netherlands). Cancer Causes Control. 2002;13(6):573–582.
35.
MoriyaKNakagawaKSantaTOxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res. 2001;61(11):4365–4370.
36.
SemenzaGLRothPHFangHMWangGL. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem. 1994;269(38):23757–23763.
37.
KimJWTchernyshyovISemenzaGLDangCV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 2006;3(3):177–185.
38.
StacpoolePWKerrDSBarnesCControlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children. Pediatrics. 2006;117(5):1519–1531.
39.
StacpoolePWGilbertLRNeibergerREEvaluation of long-term treatment of children with congenital lactic acidosis with dichloroacetate. Pediatrics. 2008;121(5):e1223–e1228.
40.
BerendzenKTheriaqueDWShusterJStacpoolePW. Therapeutic potential of dichloroacetate for pyruvate dehydrogenase complex deficiency. Mitochondrion. 2006;6(3):126–135.
41.
SunRCFadiaMDahlstromJEParishCRBoardPGBlackburnAC. Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo. Breast Cancer Res Treat. 2010;120(1):253–260.
42.
BonnetSArcherSLAllalunis-TurnerJA mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell. 2007;11(1):37–51.
43.
DharSLippardSJ. Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate. Proc Natl Acad Sci U S A. 2009;106(52):22199–22204. PMCID: 2799774.
44.
PlasDRThompsonCB. Cell metabolism in the regulation of programmed cell death. Trends Endocrinol Metab. 2002;13(2):75–78.
45.
KimJWDangCV. Multifaceted roles of glycolytic enzymes. Trends Biochem Sci. 2005;30(3):142–150.
46.
KimJWDangCV. Cancer’s molecular sweet tooth and the Warburg effect. Cancer Res. 2006;66(18):8927–8930.
47.
XuRHPelicanoHZhouYInhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res. 2005;65(2):613–621.
48.
StacpoolePW. The pharmacology of dichloroacetate. Metabolism. 1989;38(11):1124–1144.
49.
SugdenMCHolnessMJ. Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs. Am J Physiol Endocrinol Metab. 2003;284(5):E855–E862.
50.
HowlettRAHeigenhauserGJHultmanEHollidge-HorvatMGSprietLL. Effects of dichloroacetate infusion on human skeletal muscle metabolism at the onset of exercise. Am J Physiol. 1999;277(1 Pt 1):E18–E25.
51.
ParolinMLSprietLLHultmanEEffects of PDH activation by dichloroacetate in human skeletal muscle during exercise in hypoxia. Am J Physiol Endocrinol Metab. 2000;279(4):E752–E761.
52.
BeckmanKBAmesBN. The free radical theory of aging matures. Physiol Rev. 1998;78(2):547–581.
53.
ChoiJYNeuhouserMLBarnettMJIron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort. Carcinogenesis. 2008;29(5):964–970. PMCID: 2902382.
54.
CoussensLMWerbZ. Inflammation and cancer. Nature. 2002;420(6917):860–867. PMCID: 2803035.
55.
FinkelTHolbrookNJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000;408(6809):239–247.
56.
GalijasevicSSaedGMDiamondMPAbu-SoudHM. Myeloperoxidase up-regulates the catalytic activity of inducible nitric oxide synthase by preventing nitric oxide feedback inhibition. Proc Natl Acad Sci USA. 2003;100(25):14766–14771.
